EQS-Adhoc: Symrise AG decides to divest its terpenes business and makes non-cash impairment. Symrise AG's investment in Swedencare AB is subject to a non-cash impairment.

12.01.26 19:27 Uhr

Werte in diesem Artikel
Aktien

72,74 EUR -0,72 EUR -0,98%

EQS-Ad-hoc: Symrise AG / Key word(s): Miscellaneous
Symrise AG decides to divest its terpenes business and makes non-cash impairment. Symrise AG's investment in Swedencare AB is subject to a non-cash impairment.

12-Jan-2026 / 19:27 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

Wer­bung


Disclosure of inside information pursuant to Article 17 of Regulation (EU) No 596/2014

 

Symrise AG decides to divest its terpenes business and makes non-cash impairment

Symrise AG's investment in Swedencare AB is subject to a non-cash impairment

 

Wer­bung

This publication contains two separate independent inside information.
 
  1. Symrise AG is in advanced talks with potential interested parties about the sale of its terpenes business. This is a structured bidding process. Based on the offers received so far, the international accounting standard IFRS 5 will be applied. In this context, a non-cash impairment charge of approximately EUR 145 million is recorded in the fourth quarter of 2025. This has a negative impact on Symrise AG's EBIT.
  2. According to preliminary calculations, a non-cash impairment in the value of the investment in Sweden-listed Swedencare AB will lead to a material deviation from the expected result for the 2025 financial year compared to current capital market expectations and the published forecast. Symrise AG will record a non-cash impairment charge of the investment in Swedencare AB in the amount of EUR 150 million in the fourth quarter of 2025. This has a negative impact on EBITDA. 
Neither measure has any impact on the liquidity and/or operating business of Symrise AG. They will be adjusted as part of the earnings reporting.
 

Media contact:                                               Investor Relations Contact
Bernhard Kott                                                  René Weinberg
Phone: +49 (0)5531 90-1721                           Phone: +49 (0)5531 90-1879
E-mail: bernhard.kott@symrise.com               E-mail: rene.weinberg@symrise.com
 


End of Inside Information

12-Jan-2026 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


Language: English
Company: Symrise AG
Mühlenfeldstraße 1
37603 Holzminden
Germany
Phone: +49 (0)5531 90 0
E-mail: ir@symrise.com
Internet: www.symrise.com
ISIN: DE000SYM9999, DE000SYM7787, DE000SYM7704
WKN: SYM999
Indices: DAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 2258790

 
End of Announcement EQS News Service

Wer­bung

2258790  12-Jan-2026 CET/CEST

Ausgewählte Hebelprodukte auf Symrise

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Symrise

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Nachrichten zu Symrise AG

Wer­bung

Analysen zu Symrise AG

DatumRatingAnalyst
19.01.2026Symrise HoldJoh. Berenberg, Gossler & Co. KG (Berenberg Bank)
16.01.2026Symrise KaufenDZ BANK
16.01.2026Symrise Equal WeightBarclays Capital
13.01.2026Symrise BuyDeutsche Bank AG
13.01.2026Symrise BuyUBS AG
DatumRatingAnalyst
16.01.2026Symrise KaufenDZ BANK
13.01.2026Symrise BuyDeutsche Bank AG
13.01.2026Symrise BuyUBS AG
13.01.2026Symrise OverweightJP Morgan Chase & Co.
06.01.2026Symrise OverweightMorgan Stanley
DatumRatingAnalyst
19.01.2026Symrise HoldJoh. Berenberg, Gossler & Co. KG (Berenberg Bank)
16.01.2026Symrise Equal WeightBarclays Capital
16.12.2025Symrise Equal WeightBarclays Capital
11.11.2025Symrise NeutralGoldman Sachs Group Inc.
29.10.2025Symrise HoldJoh. Berenberg, Gossler & Co. KG (Berenberg Bank)
DatumRatingAnalyst
13.01.2026Symrise UnderperformJefferies & Company Inc.
11.11.2025Symrise UnderperformJefferies & Company Inc.
28.10.2025Symrise UnderperformJefferies & Company Inc.
28.10.2025Symrise UnderperformJefferies & Company Inc.
29.09.2025Symrise UnderperformJefferies & Company Inc.

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Symrise AG nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen